Endosymbionts in Trichomonas Vaginalis Pathogenicity

NCT ID: NCT07082127

Last Updated: 2025-07-24

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 700 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-10-31
• Study Completion Date: 2027-10-31

Brief Summary

With this project, the investigators aim to expand knowledge on the molecular epidemiology of Trichomonas vaginalis, thereby also evaluating the endosymbionts (Mycoplasma hominis and Trichomonas vaginalis virus) and their impact on T. vaginalis virulence. A key aspect of the study is the direct comparison between identical T. vaginalis isolates harbouring endosymbionts and those from which the endosymbionts have been removed or inhibited. For this purpose T. vaginalis clinical isolates collected in Outpatients' Centre for Infectious Venereal and Dermatological Diseases, Vienna from patients specimens (vaginal swabs or urine) will be tested. Mycoplasma hominis isolates already collected from patients samples will also be analyzed and compared with M. hominis, which are T. vaginalis endosymbionts.

In addition, 700 samples from female sex workers in Austria, who undergo regular medical check-ups, will be examined. The prevalence of sexually transmitted diseases (STDs) will be evaluated using DNA extracted from vaginal swabs, with a particular focus on parasite Trichomonas vaginalis and bacterium M. hominis. Of particular interest is the study of the prevalence of these organisms in a cohort of women who are at increased risk of infection with these pathogens due to their occupation. Moreover, the study will provide detailed information on possible co-infections, as data from routine screenings are available.

Detailed Description

For this specific project, patient samples will be cultured in Outpatients' Centre for Infectious Venereal and Dermatological Diseases, Vienna on modified Columbia agar. Specimens will be collected either with a swab, which is then smeared onto the agar plates, or as urine samples, which will be directly spread onto the agar plates. Agar plates that show growth of T. vaginalis after one week of anaerobic incubation at 37°C or M. hominis after two days of anaerobic incubation at 37°C will be set aside. Positive cultures on these agar plates will be collected and transferred to Institute for Specific Prophylaxis and Tropical Medicine (ISPTM) Medical University of Vienna. T. vaginalis and M. hominis isolates will be used for the further characterization. It is planned to remove endosymbionts from the collected T. vaginalis isolates and then test their viability, cytotoxicity, release of pro-inflammatory cytokines and nitric oxide production. M. hominis will be released from T. vaginalis using plasmocin, whereas 2'-C-methylcytidine will be used for Trichomonas vaginalis virus inhibitory assay. The lactase dehydrogenase assay (LDH) will be used to determine cytotoxicity of primary vaginal cells after contact with different T. vaginalis isolates. THP-1 cells (cells derived from leukemia monocytes) will be stimulated with different T. vaginalis isolates and proinflammatory cytokine and nitric oxide production will be evaluated. The expression profiles of putative virulence genes in M. hominis endosymbionts will be also tested. Detection of Ureaplasma spp. DNA in the DNA isolated from T. vaginalis isolates will be performed by PCR and presence confirmed by immunofluorescence and Ureaplasma-specific antibodies.

Vaginal swabs from individual sex-workers (delivered from Austrian Agency for Health and Food Safety) will be used for DNA isolation. For the detection of pathogens, we will use protocols that we have established in our previous studies. Amplified products will be sent for sequencing and compared with reference sequences from GenBank.

Conditions

Trichomonas Infection

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Trichomonas vaginalis positive samples (vaginal swabs/urine) from Outpatients' Centre for Infectious Venereal and Dermatological Diseases
• female sex-workers subjected to routine testing at Austrian Agency for Health and Food Safety

Exclusion Criteria

• samples negative for Trichomonas vaginalis from Outpatients' Centre for Infectious Venereal and Dermatological Diseases

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

Medical University of Vienna

OTHER

Sponsor Role: lead

Responsible Party

Iwona Lesiak-Markowicz

PhD

Responsibility Role: PRINCIPAL_INVESTIGATOR

Other Identifiers

FWF-ID KLP6210324

Identifier Type: -

Identifier Source: org_study_id